Itron, Inc. $ITRI Shares Sold by Amundi

Amundi trimmed its stake in shares of Itron, Inc. (NASDAQ:ITRI) by 1.3% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 917,594 shares of the scientific and technical instruments company’s stock after selling 11,813 shares during the period. Amundi owned about 2.01% of Itron worth $120,783,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also modified their holdings of ITRI. Twin Peaks Wealth Advisors LLC acquired a new stake in Itron during the 2nd quarter worth about $30,000. Bessemer Group Inc. increased its position in shares of Itron by 125.7% in the second quarter. Bessemer Group Inc. now owns 255 shares of the scientific and technical instruments company’s stock worth $34,000 after acquiring an additional 142 shares in the last quarter. Northwestern Mutual Wealth Management Co. raised its holdings in shares of Itron by 343.6% during the second quarter. Northwestern Mutual Wealth Management Co. now owns 346 shares of the scientific and technical instruments company’s stock valued at $46,000 after acquiring an additional 268 shares during the period. EverSource Wealth Advisors LLC raised its holdings in shares of Itron by 25.3% during the second quarter. EverSource Wealth Advisors LLC now owns 401 shares of the scientific and technical instruments company’s stock valued at $53,000 after acquiring an additional 81 shares during the period. Finally, REAP Financial Group LLC lifted its position in shares of Itron by 168.4% in the 2nd quarter. REAP Financial Group LLC now owns 424 shares of the scientific and technical instruments company’s stock valued at $56,000 after acquiring an additional 266 shares in the last quarter. Institutional investors and hedge funds own 96.19% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts have weighed in on ITRI shares. Oppenheimer set a $145.00 price objective on shares of Itron and gave the stock an “outperform” rating in a research report on Friday, October 31st. Weiss Ratings reiterated a “buy (b-)” rating on shares of Itron in a report on Monday, December 1st. Argus reissued a “hold” rating on shares of Itron in a research note on Tuesday, November 4th. Baird R W cut Itron from a “strong-buy” rating to a “hold” rating in a research note on Friday, October 31st. Finally, Robert W. Baird reissued a “neutral” rating and issued a $118.00 price target (down from $137.00) on shares of Itron in a research report on Friday, October 31st. Nine analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $139.00.

Insider Buying and Selling

In other news, CFO Joan S. Hooper sold 948 shares of the stock in a transaction on Monday, November 24th. The shares were sold at an average price of $96.51, for a total transaction of $91,491.48. Following the transaction, the chief financial officer owned 87,446 shares in the company, valued at $8,439,413.46. This represents a 1.07% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, SVP Donald L. Reeves III sold 536 shares of the firm’s stock in a transaction on Monday, November 24th. The shares were sold at an average price of $96.51, for a total transaction of $51,729.36. Following the transaction, the senior vice president owned 19,068 shares in the company, valued at $1,840,252.68. This represents a 2.73% decrease in their position. The SEC filing for this sale provides additional information. Over the last three months, insiders sold 2,971 shares of company stock valued at $286,731. 1.51% of the stock is owned by company insiders.

Itron Stock Performance

Shares of ITRI stock opened at $97.87 on Monday. Itron, Inc. has a fifty-two week low of $90.11 and a fifty-two week high of $142.00. The stock’s 50-day moving average is $113.82 and its two-hundred day moving average is $121.57. The company has a debt-to-equity ratio of 0.46, a current ratio of 2.17 and a quick ratio of 1.91. The firm has a market cap of $4.48 billion, a P/E ratio of 17.60, a PEG ratio of 0.48 and a beta of 1.52.

Itron (NASDAQ:ITRI) last announced its quarterly earnings results on Thursday, October 30th. The scientific and technical instruments company reported $1.54 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.48 by $0.06. Itron had a return on equity of 17.82% and a net margin of 10.69%.The business had revenue of $581.63 million during the quarter, compared to analyst estimates of $578.49 million. During the same period in the previous year, the company earned $1.84 EPS. The firm’s revenue was down 5.5% on a year-over-year basis. Itron has set its FY 2025 guidance at 6.840-6.940 EPS and its Q4 2025 guidance at 2.150-2.250 EPS. Analysts predict that Itron, Inc. will post 5.33 earnings per share for the current fiscal year.

About Itron

Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.